; and (B) by striking subsection (c) and all that follows through the period at the end and inserting subsection (c). ; and (2) by striking paragraph (4). 204. Reauthorization; reporting requirements (a) Performance Reports Section 738A(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–1(a) ) is amended— (1) in paragraph (1)— (A) in subparagraph (A)— (i) by striking 2013 and inserting 2018 ; and (ii) by striking the Medical Device User Fee Amendments of 2012 and inserting Medical Device User Fee Amendments of 2017 ; and (B) in subparagraph (B), by striking the Medical Device User Fee Amendments of 2012 and inserting Medical Device User Fee Amendments of 2017 ; and (2) in paragraph (2), by striking 2013 through 2017 and inserting 2018 through 2022 . (b) Reauthorization Section 738A(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–1(b) ) is amended— (1) in paragraph (1), by striking 2017 and inserting 2022 ; and (2) in paragraph (5), by striking 2017 and inserting 2022 . 205. Conformity assessment pilot program (a) In general Section 514 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360d ) is amended by adding at the end the following: (d) Pilot accreditation scheme for conformity assessment (1) In general The Secretary shall establish a pilot program under which— (A) testing laboratories may be accredited, by accreditation bodies meeting criteria specified by the Secretary, to assess the conformance of a device with certain standards recognized under this section